Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Express Scripts
Citi
Argus Health
Fuji
Mallinckrodt
AstraZeneca
Harvard Business School
US Army

Generated: December 17, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR TERAZOSIN HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Terazosin Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00007592 Hypertension Screening and Treatment Program Completed VA Office of Research and Development N/A Hypertension is one of the most common medical problems in the United States and in the VA health care system. It has been well-documented that hypertension can be effectively treated. However, there remain important unresolved clinical questions in the area of antihypertensive treatment. For example, how much is mortality affected by visit compliance, blood pressure control and type of antihypertensive agent? Or, are some regimens associated with more morbidity than others? Or, are there inexpensive regimens that are as effective as more expensive regimens? The amount of data that is available from this demonstration project (currently 6,100 patients) will help address these questions. The answers to these questions should result in better care for veterans with hypertension.
NCT00201630 Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy Unknown status Sanofi Phase 3 To asess the efficacy of Uroxatrol, an alpha blocker in men undergoing prostate brachytherapy to treat prostate cancer, and whether the use of Uroxatrol in advance of the brachytherapy is better or not than starting it on the day of surgery.
NCT00201630 Prophylactic Vs. Therapeutic Use of Uroxatrol in Men Undergoing Brachytherapy Unknown status New York Prostate Institute Phase 3 To asess the efficacy of Uroxatrol, an alpha blocker in men undergoing prostate brachytherapy to treat prostate cancer, and whether the use of Uroxatrol in advance of the brachytherapy is better or not than starting it on the day of surgery.
NCT00237510 Pilot Study of Terazosin in Treatment of Antidepressant Induced Excessive Sweating Completed Thomas Jefferson University N/A This study is based on the hypothesis that terazosin, a blocker of alpha-1 receptors, will be effective in reducing excessive sweating caused by antidepressant treatment, and will have minimal adverse effects.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Terazosin Hydrochloride

Condition Name

Condition Name for Terazosin Hydrochloride
Intervention Trials
Hypertension 2
Prostatic Hyperplasia 2
Benign Prostatic Hyperplasia 2
Hyperhidrosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Terazosin Hydrochloride
Intervention Trials
Prostatic Hyperplasia 4
Hyperplasia 4
Hyperhidrosis 3
Hypertension 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Terazosin Hydrochloride

Trials by Country

Trials by Country for Terazosin Hydrochloride
Location Trials
United States 22
China 3
Korea, Republic of 2
Iran, Islamic Republic of 1
Puerto Rico 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Terazosin Hydrochloride
Location Trials
Pennsylvania 4
California 3
Tennessee 2
Florida 2
Washington 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Terazosin Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Terazosin Hydrochloride
Clinical Trial Phase Trials
Phase 4 3
Phase 3 1
Phase 2/Phase 3 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Terazosin Hydrochloride
Clinical Trial Phase Trials
Completed 8
Recruiting 2
Terminated 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Terazosin Hydrochloride

Sponsor Name

Sponsor Name for Terazosin Hydrochloride
Sponsor Trials
Thomas Jefferson University 3
Capital Medical University 1
Hospital Authority, Hong Kong 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Terazosin Hydrochloride
Sponsor Trials
Other 20
Industry 4
U.S. Fed 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Farmers Insurance
Moodys
McKinsey
Accenture
Cantor Fitzgerald
QuintilesIMS
Covington
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.